Skip to main content
Top
Published in: BMC Cancer 1/2017

Open Access 01-12-2017 | Research article

Treatment recommendations within the leeway of clinical guidelines: A qualitative interview study on oncologists’ clinical deliberation

Authors: I. Otte, S. Salloch, A. Reinacher-Schick, J. Vollmann

Published in: BMC Cancer | Issue 1/2017

Login to get access

Abstract

Background

Recommending the optimal treatment for an individual patient requires a well-balanced consideration of various medical, social and ethical factors. The interplay of these factors, interpretation of the patient’s situation and understanding of the existing clinical guidelines can lead to divergent therapy recommendations, depending on the attending physician. Gaining a better understanding of the individual process of medical decision-making and the differences occurring will support the delivery of optimal individualized care within the clinical setting.

Methods

A case vignette of a 64-year-old patient with locally advanced pancreatic adenocarcinoma was discussed with oncologists in 14 qualitative, semi-structured interviews at two academic institutions. Relevant factors that emerged were ranked by the participants using the Q card sorting method. Qualitative data analysis and descriptive statistics were performed.

Results

Oncologists recommend different therapeutic approaches within the leeway of the relevant clinical guidelines. One group of participants endorses a rather aggressive and potentially curative approach with a combination chemotherapy following the FOLFIRINOX protocol to provide the patient with the best chances of resectability. The second group suggests a milder chemotherapy approach with gemcitabine, highlighting the palliative approach and the patient’s quality of life. Clinical guidelines are generally seen as an important point of reference, but are complicated to apply in highly individual cases.

Conclusion

The physician’s individual assessment of factors, such as biological age, general condition or prognosis, plays a decisive role in treatment recommendations, particularly in those cases which are not fully covered by guidelines. Judgment and discretion remain crucial in clinical decision-making and cannot and should not be fully ruled out by evidence-based guidelines. Therefore, a more comprehensive reflection on the interaction between evidence-based medicine and the physician’s estimation of each individual case is desirable. Knowledge of existing barriers can enhance the implementation of guidelines, for example, through medical education.
Appendix
Available only for authorised users
Literature
1.
go back to reference Konstantara E, Vandrevala T, Cox A, Creagh-Brown BC, Ogden J. Balancing professional tension and deciding upon the status of death: making end-of-life decisions in intensive care units. Health Psychol Open. 2016;3(1):2191–6.CrossRef Konstantara E, Vandrevala T, Cox A, Creagh-Brown BC, Ogden J. Balancing professional tension and deciding upon the status of death: making end-of-life decisions in intensive care units. Health Psychol Open. 2016;3(1):2191–6.CrossRef
2.
go back to reference Zwolsman SE, van Dijk N, te Pas E, Wieringa-de WM. Barriers to the use of evidence-based medicine: knowledge and skills, attitude, and external factors. Perspect Med Educ. 2013;2(1):4–13.CrossRefPubMedPubMedCentral Zwolsman SE, van Dijk N, te Pas E, Wieringa-de WM. Barriers to the use of evidence-based medicine: knowledge and skills, attitude, and external factors. Perspect Med Educ. 2013;2(1):4–13.CrossRefPubMedPubMedCentral
3.
go back to reference Carlsen B, Norheim OF. “what lies beneath it all?” an interview study of GPs’ attitudes to the use of guidelines. BMC Health Serv Res. 2008;8:218.CrossRefPubMedPubMedCentral Carlsen B, Norheim OF. “what lies beneath it all?” an interview study of GPs’ attitudes to the use of guidelines. BMC Health Serv Res. 2008;8:218.CrossRefPubMedPubMedCentral
4.
go back to reference Freeman AC, Sweeney K. Why general practitioners do not implement evidence: qualitative study. BMJ. 2001;323(1):1–5. Freeman AC, Sweeney K. Why general practitioners do not implement evidence: qualitative study. BMJ. 2001;323(1):1–5.
5.
go back to reference Yellen SB, Cella DF, Leslie WT. Age and clinical decision making in oncology patients. J Natl Cancer Inst. 1994;86(23):1766–70.CrossRefPubMed Yellen SB, Cella DF, Leslie WT. Age and clinical decision making in oncology patients. J Natl Cancer Inst. 1994;86(23):1766–70.CrossRefPubMed
6.
go back to reference McKinlay JB, Potter DA, Feldman HA. Non-medical influences on medical decision-making. Soc Sci Med. 1996;42(5):769–76.CrossRefPubMed McKinlay JB, Potter DA, Feldman HA. Non-medical influences on medical decision-making. Soc Sci Med. 1996;42(5):769–76.CrossRefPubMed
7.
go back to reference Petrisek AC, Laliberte LL, Allen SM, Mor V. The treatment decision-making process: age differences in a sample of women recently diagnosed with nonrecurrent, early-stage breast cancer. Gerontologist. 1997;37(5):598–608.CrossRefPubMed Petrisek AC, Laliberte LL, Allen SM, Mor V. The treatment decision-making process: age differences in a sample of women recently diagnosed with nonrecurrent, early-stage breast cancer. Gerontologist. 1997;37(5):598–608.CrossRefPubMed
8.
go back to reference Bridges J, Hughes J, Farrington N, Richardson A. Cancer treatment decision-making processes for older patients with complex needs: a qualitative study. BMJ Open. 2015;5(12):e009674.CrossRefPubMedPubMedCentral Bridges J, Hughes J, Farrington N, Richardson A. Cancer treatment decision-making processes for older patients with complex needs: a qualitative study. BMJ Open. 2015;5(12):e009674.CrossRefPubMedPubMedCentral
9.
go back to reference Jiwa M, Meng X, O'Shea C, Magin P, Dadich A, Pillar V. How do general practitioners manage patients with cancer symptoms? A video-vignette study. BMJ Open. 2015;5(9):e008525.CrossRefPubMedPubMedCentral Jiwa M, Meng X, O'Shea C, Magin P, Dadich A, Pillar V. How do general practitioners manage patients with cancer symptoms? A video-vignette study. BMJ Open. 2015;5(9):e008525.CrossRefPubMedPubMedCentral
10.
go back to reference Redelmeier DA, Shafir E. Medical decision making in situations that offer multiple alternatives. JAMA. 1995;273(4):302–5.CrossRefPubMed Redelmeier DA, Shafir E. Medical decision making in situations that offer multiple alternatives. JAMA. 1995;273(4):302–5.CrossRefPubMed
11.
15.
go back to reference Miesfeldt S, Murray K, Lucas L, Chang CH, Goodman D, Morden NE. Association of age, gender, and race with intensity of end-of-life care for medicare beneficiaries with cancer. J Palliat Med. 2012;15(5):548–54.CrossRefPubMedPubMedCentral Miesfeldt S, Murray K, Lucas L, Chang CH, Goodman D, Morden NE. Association of age, gender, and race with intensity of end-of-life care for medicare beneficiaries with cancer. J Palliat Med. 2012;15(5):548–54.CrossRefPubMedPubMedCentral
16.
go back to reference Sheffield KM, Boyd CA, Benarroch-Gampel J, Kuo YF, Cooksley CD, Riall TS. End-of-life care in medicare beneficiaries dying with pancreatic cancer. Cancer. 2011;117(21):5003–12.CrossRefPubMedPubMedCentral Sheffield KM, Boyd CA, Benarroch-Gampel J, Kuo YF, Cooksley CD, Riall TS. End-of-life care in medicare beneficiaries dying with pancreatic cancer. Cancer. 2011;117(21):5003–12.CrossRefPubMedPubMedCentral
17.
go back to reference Ho TH, Barbera L, Saskin R, Lu H, Neville BA, Earle CC. Trends in the aggressiveness of end-of-life cancer care in the universal health care system of Ontario. J Clin Oncol. 2011;29(12):1587–91.CrossRefPubMedPubMedCentral Ho TH, Barbera L, Saskin R, Lu H, Neville BA, Earle CC. Trends in the aggressiveness of end-of-life cancer care in the universal health care system of Ontario. J Clin Oncol. 2011;29(12):1587–91.CrossRefPubMedPubMedCentral
18.
go back to reference Virnig BA, Morgan RO, Persily NA, DeVito CA. Racial and income differences in use of the hospice benefit between the medicare managed care and medicare fee-for-service. J Palliat Med. 1999;2(1):23–31.CrossRefPubMed Virnig BA, Morgan RO, Persily NA, DeVito CA. Racial and income differences in use of the hospice benefit between the medicare managed care and medicare fee-for-service. J Palliat Med. 1999;2(1):23–31.CrossRefPubMed
19.
go back to reference Zwolsman S, te Pas E, Hooft L, Wieringa-de Waard M, van Dijk N. Barriers to GPs’ use of evidence-based medicine: a systematic review. Br J Gen Pract. 2012;62(600):511–21.CrossRef Zwolsman S, te Pas E, Hooft L, Wieringa-de Waard M, van Dijk N. Barriers to GPs’ use of evidence-based medicine: a systematic review. Br J Gen Pract. 2012;62(600):511–21.CrossRef
Metadata
Title
Treatment recommendations within the leeway of clinical guidelines: A qualitative interview study on oncologists’ clinical deliberation
Authors
I. Otte
S. Salloch
A. Reinacher-Schick
J. Vollmann
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2017
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-017-3783-6

Other articles of this Issue 1/2017

BMC Cancer 1/2017 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine